Merck to test single-dose regimen of HPV vaccine Gardasil 9
Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a single-dose regimen compared to t...
Here's Why Merck (MRK) Gained But Lagged the Market Today
Merck (MRK) reachead $123.99 at the closing of the latest trading day, reflecting a +0.19% change compared to its last close.
Merck to Participate in the Barclays 26th Annual Global Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Participate in the Barclays 26th Annual Global Healthcare Conference.
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, Merck (MRK) closed at $126.96, indicating a -0.15% shift from the previous trading day.
Merck: A Great Dividend Growth Stock, But Not At This Price
Merck: A Great Dividend Growth Stock, But Not At This Price
3 Long-Term Winners from Charles Schwab's Top Picks
Despite markets continuing at record highs, Charles Schwab (NYSE: SCHW ) Investment Management still identifies investment opportunities within long-term stocks. According to its recent filings, th...
Merck's Bridion faces generic threat from drugmaker Hikma
Merck has received a letter that Hikma Pharmaceuticals US unit has sought a pre-patent expiry approval from the US FDA to sell a generic version of its Bridion injection, the drugmaker said in fili...
Merck Deal Boosts Founder Of Little-Known Korean Biotech Company Into Billionaire Ranks
Amid a frenzy for AI-related stocks, shares of a little-known biotech company in South Korea got an Nvidia-esque boost. Alteogen, a pharmaceutical company with nothing to do with AI, saw its share ...
2 Dow Stocks That Have Been Most Overbought Since The 1970s
2 Dow Stocks That Have Been Most Overbought Since The 1970s
Merck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B
Merck's (MRK) Animal Health unit is set to strengthen its position with the acquisition of Elanco Animal Health's aqua business for $1.3 billion. The transaction is expected to close by mid-2024.
Why Merck Stock Rocketed Nearly 5% Skyward Today
The healthcare giant published its fourth-quarter and full-year 2023 results. It beat on both the top and bottom lines for the quarter.
Merck Stock Hits Record High on Sales of Cancer Drugs, Vaccines
Merck & Co. (MRK) shares traded at an all-time high Thursday after the pharmaceutical company posted a surprisingly positive adjusted profit after sales jumped for its cancer drugs and vaccines.
Merck (MRK) Q4 Earnings Beat, Sales Miss, Upbeat '24 View
Merck (MRK) beats Q4 estimates for earnings but misses the mark on sales. The company issues an encouraging 2024 guidance.
Merck & Co., Inc. (MRK) Q4 2023 Earnings Call Transcript
Merck & Co., Inc. (MRK) Q4 2023 Earnings Call Transcript
Merck (MRK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Merck (MRK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim...
Related Companies